1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Computed Tomography (CT) Systems Overview

3 Products under Development

• 3.1 Computed Tomography (CT) Systems - Pipeline Products by Stage of Development
• 3.2 Computed Tomography (CT) Systems - Pipeline Products by Segment
• 3.3 Computed Tomography (CT) Systems - Pipeline Products by Territory
• 3.4 Computed Tomography (CT) Systems - Pipeline Products by Regulatory Path
• 3.5 Computed Tomography (CT) Systems - Pipeline Products by Estimated Approval Date
• 3.6 Computed Tomography (CT) Systems - Ongoing Clinical Trials

4 Computed Tomography (CT) Systems - Pipeline Products under Development by Companies

• 4.1 Computed Tomography (CT) Systems Companies - Pipeline Products by Stage of Development
• 4.2 Computed Tomography (CT) Systems - Pipeline Products by Stage of Development

5 Computed Tomography (CT) Systems Companies and Product Overview

• 5.1 California Institute of Technology Company Overview
• 5.2 Canon Medical Systems Corp Company Overview
• 5.3 Canon Medical Systems USA, Inc. Company Overview
• 5.4 Duke University Company Overview
• 5.5 Fermilab Company Overview
• 5.6 FMI Medical Systems Inc Company Overview
• 5.7 German Cancer Research Center Company Overview
• 5.8 Hitachi Ltd Company Overview
• 5.9 iCAD Inc Company Overview
• 5.10 Imalux Corporation Company Overview
• 5.11 Johns Hopkins University Company Overview
• 5.12 Koninklijke Philips NV Company Overview
• 5.13 MARS Bioimaging Ltd Company Overview
• 5.14 Massachusetts General Hospital Company Overview
• 5.15 National Institutes of Health Clinical Center Company Overview
• 5.16 Neusoft Medical Systems Co Ltd Company Overview
• 5.17 Philips Healthcare Company Overview
• 5.18 Picofemto LLC Company Overview
• 5.19 Samsung Medison Co Ltd Company Overview
• 5.20 Siemens Healthineers AG Company Overview
• 5.21 Stanford University Company Overview
• 5.22 Stellarray, Inc. Company Overview
• 5.23 The Hong Kong University of Science and Technology Company Overview
• 5.24 Tribogenics, Inc. Company Overview
• 5.25 University of Antwerp Company Overview
• 5.26 University of California Santa Cruz Company Overview
• 5.27 University of Washington Company Overview
• 5.28 Varian Medical Systems Inc Company Overview
• 5.29 Zumatek Inc Company Overview

6 Computed Tomography (CT) Systems- Recent Developments

• 6.1 Apr 11, 2019: Median Technologies reports full year 2018 financial results
• 6.2 Apr 04, 2019: BGU Researchers first to show how hackers can dupe radiologists and AI software by manipulating Lung Cancer Scans
• 6.3 Mar 28, 2019: iCAD appoints Stacey Stevens as president
• 6.4 Mar 27, 2019: Stryker announces new Vice President, chief legal officer
• 6.5 Mar 27, 2019: ContextVision names Fredrik Palm as new CEO
• 6.6 Mar 26, 2019: Philips unveils new telehealth services for precision diagnoses
• 6.7 Mar 26, 2019: VA 3D printing proves more useful for shoulder-surgery planning than current visualization methods
• 6.8 Mar 25, 2019: EDP and European Commission promote deals between startups and global companies
• 6.9 Mar 22, 2019: Canon Medical streamlines workflow and offers advanced imaging with new angiography system at SIR 2019
• 6.10 Mar 21, 2019: Baptist Health-Hot spring county introduces new state-of-the-art radiology equipment

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us

Computed Tomography (CT) Systems - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Computed Tomography (CT) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of Computed Tomography (CT) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Computed Tomography (CT) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Computed Tomography (CT) Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Computed Tomography (CT) Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Computed Tomography (CT) Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.